Possibile role of vascular endothelial growth factor (VEGF) levels in immunodepleted plasma of metastatic colorectal cancer (mCRC) patients (pts) treated with a biweekly administration of capecitabine plus oxaliplatin (XELOX-2) plus bevacizumab: Preliminary results.
N. Silvestris
No relevant relationships to disclose
A. Azzariti
No relevant relationships to disclose
L. Porcelli
No relevant relationships to disclose
A. E. Quatrale
No relevant relationships to disclose
A. Paradiso
No relevant relationships to disclose
G. Colucci
No relevant relationships to disclose